Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon Complication
Surgical Infections · 01.10.2025 · 26 (8) · 561-566
DOI: 10.1089/sur.2025.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Infections, online erschienen am 22.04.2025. Verfasst von Pablo Gomes-da Silva de Rosenzweig und 3 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Lung Transplant Laboratory, Instituto Nacional de Enfermedades Respiratorias "Dr Ismael Cosío Villegas", Mexico City, Mexico. Hauptthemen laut MEDLINE: Splenomegaly, Splenectomy, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
The objective of this study was to describe the clinical and microbiologic characteristics of adult patients with HIV infection and splenomegaly treated with splenectomy.
Methods
We conducted a retrospective study, including patients with the diagnosis of HIV and splenomegaly treated with splenectomy between 2005 and 2023.
Results
We included 20 patients with a mean age of 36 years (±2), with a predominance of males (n = 18). Some patients had more than one condition associated with splenomegaly. The following were considered as the indication for splenectomy: Splenic abscesses in 13 (65%), refractory thrombocytopenia in 9 (45%), symptomatic splenomegaly in 5 (25%), and splenic lymphoma in 1 (5%). After operation, spleen samples were sent for microbiology culture, displaying the invasion of bacteria in 11 (55%), fungi in 8 (40%), and viruses in 8 (40%). When evaluating the indications for splenectomy between groups, splenic abscesses were more present in those patients without active treatment (83% vs. 38%, p = 0.035), whereas symptomatic splenomegaly presented more frequently in those with active antiretroviral therapy (ART; 63% vs. 0%, p = 0.004).
Conclusions
The cornerstone of treatment for patients with splenomegaly should initially focus on adherence to ART and addressing the underlying cause. However, when the condition is refractory splenectomy may be indicated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Lung Transplant Laboratory, Instituto Nacional de Enfermedades Respiratorias "Dr Ismael Cosío Villegas", Mexico City, Mexico.
- Postgraduate Department, Escuela Superior de Medicina, Instituto Politecnico Nacional, Mexico City, Mexico.
- Thoracic Surgery Department, Instituto Nacional de Enfermedades Respiratorias "Dr Ismael Cosío Villegas", Mexico City, Mexico.
- Medical Direction, Instituto Nacional de Enfermedades Respiratorias "Dr Ismael Cosío Villegas", Mexico City, Mexico.
ORCID-Profile: Oscar Mario Delgado-Casillas
Zitieren
APA
Gomes-da Silva de Rosenzweig, P., Delgado-Casillas, O. M., Vázquez-Minero, J. C., & Vega-Barrientos, R. S. (2025). Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon Complication. Surgical Infections, 26(8), 561-566. https://doi.org/10.1089/sur.2025.003
Vancouver
Gomes-da Silva de Rosenzweig P, Delgado-Casillas OM, Vázquez-Minero JC, Vega-Barrientos RS. Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon Complication. Surgical Infections. 2025;26(8):561-566. doi:10.1089/sur.2025.003
BibTeX
@article{GomesdaSilvadeRosenzweig2025,
author = {Gomes-da Silva de Rosenzweig, Pablo and Delgado-Casillas, Oscar Mario and Vázquez-Minero, Juan Carlos and Vega-Barrientos, Ricardo Stanley},
title = {Splenectomy for the Treatment of Splenomegaly in People Living with HIV: An Uncommon Complication},
journal = {Surgical Infections},
year = {2025},
volume = {26},
number = {8},
pages = {561--566},
doi = {10.1089/sur.2025.003}
}
EUVIMED